Literature DB >> 9630371

The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease.

R C Spencer1.   

Abstract

High Clostridium difficile disease rates were originally associated with clindamycin use, but this association has declined in recent years following the decline in the clinical use of clindamycin, and disease is now particularly associated with the use of broad-spectrum antibiotics, especially the cephalosporins. There are now sufficient reports in the literature to merit the discontinuation of the widespread use of cephalosporins, especially in the elderly, by the substitution, wherever possible, with antibiotics not associated with the promotion of C. difficile-associated disease. Such agents include benzylpenicillin, gentamicin, trimethoprim, ciprofloxacin and the ureido-penicillins. Widespread education about the proper use of antibiotics in clinical practice remains essential.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630371     DOI: 10.1093/jac/41.suppl_3.21

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Preventing postoperative infections: current treatment recommendations.

Authors:  I C Gyssens
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

3.  Clostridium difficile infection in hospitals: risk factors and responses.

Authors:  Thomas J Louie; Jon Meddings
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

4.  The death of diagnosis.

Authors:  D M S Bodansky; O J Ziff; H J Bodansky
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

5.  Clinical benefit of infectious diseases consultation: a monocentric prospective cohort study.

Authors:  A de La Blanchardière; J Boutemy; P Thibon; J Michon; R Verdon; V Cattoir
Journal:  Infection       Date:  2012-06-22       Impact factor: 3.553

6.  Predictors of Clostridium difficile colitis infections in hospitals.

Authors:  R Ricciardi; K Harriman; N N Baxter; L K Hartman; R J Town; B A Virnig
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

7.  Rapid detection of Clostridium difficile in feces by real-time PCR.

Authors:  Simon D Bélanger; Maurice Boissinot; Natalie Clairoux; François J Picard; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 8.  Cefepime: a reappraisal in an era of increasing antimicrobial resistance.

Authors:  Andrea Endimiani; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

Review 9.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK.

Authors:  J A Chris Delaney; Sandra Dial; Alan Barkun; Samy Suissa
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.